Evidence map›Paper›PMID 38068850›Full record

ArticleNutrients2023

A Ropy Exopolysaccharide-Producing Strain

Hui Wang, Xinyuan Zhang, Xinfang Kou, Zhengyuan Zhai, Yanling Hao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Frontiers in microbiology · 2025
    Article
  2. Review
  3. Probiotics: Shaping the gut immunological responses.World journal of gastroenterology · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hui WangCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Xinyuan ZhangCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Xinfang KouCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Zhengyuan ZhaiCollege of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.ORCID 0000-0002-8154-1540
Yanling HaoKey Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Health, China Agricultural University, Beijing 100083, China.
China Agricultural University · CN

Funding

National Key R&D Program of China No. 2022YFF1100102National Natural Science Foundation of China No. 31972055
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a chronic disease associated with overactive inflammation and gut dysbiosis. Owing to the beneficial effects of bifidobacteria on IBD treatment, this study aimed to investigate the anti-inflammation effects of an exopolysaccharide (EPS)-producing strain

Indexed as

Bifidobacterium pseudocatenulatumColitisInflammatory Bowel DiseasesAnimalsAnti-Inflammatory AgentsBifidobacteriumColonCytokinesDextran SulfateDisease Models, AnimalDysbiosisInflammationMiceMice, Inbred C57BLAnti-Inflammatory AgentsCytokinesDextran SulfateBifidobacterium pseudocatenulatumcolitisexopolysaccharidegut microbiotaintestinal barrier

Identifiers

PMID38068850
PMCPMC10707796
OpenAlexW4389223140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.